ADIAL PHARMACEUTICALS, INC. - ADIL
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$771K
QoQ value delta ($000)
+$562K
(+268.9%)
Implied price effect (QoQ)
-36.56%
Shares
Total shares
3,536,222
QoQ shares delta
+2,928,138
(+481.54%)
Total shares held by funds (by quarter)
Market chart (ADIL)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 561 | 2,554,442 | 0.01% |
| CITADEL ADVISORS LLC | 48 | 219,621 | 0.0% |
| VANGUARD GROUP INC | 34 | 156,024 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 34 | 155,745 | 0.0% |
| JANE STREET GROUP, LLC | 26 | 121,841 | 0.0% |
| NORTHERN TRUST CORP | 14 | 65,979 | 0.0% |
| Virtu Financial LLC | 14 | 63,827 | 0.0% |
| XTX Topco Ltd | 11 | 52,097 | 0.0% |
| Manchester Capital Management LLC | 10 | 48,097 | 0.0% |
| BlackRock, Inc. | 6 | 27,770 | 0.0% |
| StoneX Group Inc. | 4 | 19,451 | 0.0% |
| TWO SIGMA SECURITIES, LLC | 3 | 17,074 | 0.0% |
| PRIVATE MANAGEMENT GROUP INC | 2 | 10,000 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2 | 12,087 | 0.0% |
| UBS Group AG | 2 | 9,167 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 205 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 160 | 0.0% |
| HARBOUR INVESTMENTS, INC. | 0 | 99 | 0.0% |
| CITIGROUP INC | 0 | 1 | 0.0% |
| MORGAN STANLEY | 0 | 9 | 0.0% |
| Tower Research Capital LLC (TRC) | 0 | 1,341 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 1,158 | 0.0% |
| Abound Wealth Management | 0 | 27 | 0.0% |